Biotech · Private company
Quotient Sciences
Track this companyFree. Adds Quotient Sciences to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials8
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy AdultsPHASE1 · NOT_YET_RECRUITING · started Oct 26, 2026ClinicalTrials.gov NCT07869654 · fetched Nov 12, 2026
- Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)PHASE1 · RECRUITING · started Nov 24, 2024ClinicalTrials.gov NCT06500793 · fetched Nov 12, 2026
- A Study to Evaluate the Effects of Phenytoin and Itraconazole on Sonrotoclax (BGB-11417) in Healthy VolunteersPHASE1 · COMPLETED · started Aug 19, 2024ClinicalTrials.gov NCT06543043 · fetched Nov 12, 2026
- First in Human Study of RVP-001, a New Manganese Based MRI Contrast AgentPHASE1 · COMPLETED · started May 18, 2022ClinicalTrials.gov NCT05413668 · fetched Nov 12, 2026
- Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)PHASE1 · COMPLETED · started Dec 1, 2021ClinicalTrials.gov NCT05090280 · fetched Nov 12, 2026
- Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc IntervalPHASE1 · UNKNOWN · started Jun 1, 2021ClinicalTrials.gov NCT04898907 · fetched Nov 12, 2026
- Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult SubjectsPHASE1 · COMPLETED · started Sep 19, 2019ClinicalTrials.gov NCT04155814 · fetched Nov 12, 2026
- Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication AdherenceNA · COMPLETED · started Jul 31, 2018ClinicalTrials.gov NCT03653897 · fetched Nov 12, 2026